The Conversation (0)
Imagin Medical (CSE:IME) (OTC PINK:IMEXF) is pleased to announce that its common shares were approved for uplisting from the Pink Open Market to the OTCQB Venture Market, effective June 28, 2018. As quoted in the press release: “Uplisting to OTCQB is an important milestone in our evolution as a public company,” commented Jim Hutchens, Imagin’s President …
Imagin Medical (CSE:IME) (OTC PINK:IMEXF) is pleased to announce that its common shares were approved for uplisting from the Pink Open Market to the OTCQB Venture Market, effective June 28, 2018.
As quoted in the press release:
“Uplisting to OTCQB is an important milestone in our evolution as a public company,” commented Jim Hutchens, Imagin’s President and CEO. “We believe this should help with our continuing efforts to broaden our exposure within the investment community, diversify our shareholder base and improve the trading liquidity of our shares.”
The OTCQB is a venture market designed for early-stage and developing U.S. and international companies. To be eligible, companies must be current in their reporting and undergo an annual verification and management certification process.
